Publication Name	World Journal of Gastroenterology
Manuscript ID	5638
Country	United States

Received	2013-09-18 11:23
Peer-Review Started	2013-09-18 14:30
To Make the First Decision	2013-11-04 19:19
Return for Revision	2013-11-11 10:46
Revised	2013-11-20 00:32
Second Decision	2014-01-06 17:58
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2014-01-06 19:06
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-02-28 15:10
Publish the Manuscript Online	2014-03-18 14:14

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Challenges in managing hepatitis C virus infection in cancer patients
Manuscript Source	Invited Manuscript
All Author List	Roy A Borchardt and Harrys A Torres
Funding Agency and Grant Number
Corresponding Author	Harrys A Torres, MD, Assistant Professor, Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, United States. htorres@mdanderson.org
Key Words	Hepatitis C virus; Cancer; Hematopoietic stem cell transplant; Chemotherapy; Treatment; Antiviral; Pegylated interferon; Ribavirin
Core Tip	Hepatitis C virus (HCV) infection adds complexity to treatment considerations of cancer patients. This is amplified by the absence of standard of care guidelines for the management of cancer patients with HCV infection. Not only can HCV infection result in the development hepatocellular cancer and non-Hodgkin lymphoma, but the presence of HCV infection in cancer patients can affect the treatment of malignancies with antineoplastic chemotherapies. Side effects of HCV therapy can be exacerbated in cancer patients due to underlying cytopenias and comorbidities. In those patients treated for HCV infection, cancer patients have poorer response to treatment than the general non-cancer population.
Publish Date	2014-03-18 14:14
Citation	Borchardt RA, Torres HA. Challenges in managing hepatitis C virus infection in cancer patients. World J Gastroenterol 2014; 20(11): 2771-2776
URL	http://www.wjgnet.com/1007-9327/full/v20/i11/2771.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i11.2771

Full Article (PDF)	WJG-20-2771.pdf
Full Article (Word)	WJG-20-2771.doc
Manuscript File	5638-Review.doc
Answering Reviewers	5638-Answering reviewers.pdf
Copyright License Agreement	5638-Copyright assignment.pdf
Peer-review Report	5638-Peer reviewer(s).pdf
Scientific Editor Work List	5638-Scientific editor work list.doc